Issued Patents 2022
Showing 1–1 of 1 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11390601 | Conformationally-restricted analogues of sorafenib and regorafenib as selective kinase inhibitors for cancer treatment | — | 2022-07-19 |
Showing 1–1 of 1 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11390601 | Conformationally-restricted analogues of sorafenib and regorafenib as selective kinase inhibitors for cancer treatment | — | 2022-07-19 |